Background illustration for clinical trials search

Paid Clinical Trials Rochester

Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Rochester MN, Chicago IL, Chicago Ridge IL,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase 3, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Rochester MN, St Louis MO, Detroit MI, Cleveland OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Rochester MN, Milwaukee WI, Chicago IL, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Rochester MN, Arlington Heights IL, Winfield IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase 3, Recruiting

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for
Hepatocellular Carcinoma (HCC)
Location: Rochester MN, Omaha NE, St Louis MO, Lexington KY,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT06726161

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: Rochester MN, Waukee IA, Milwaukee WI, Chicago IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Rochester MN, Saint Paul MN, Waterloo IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

for
Gastric Cancer, Gastro-esophageal Junction Cancer,
Location: Rochester MN, Jacksonville FL
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06005493

Phase 1, Phase 2, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Rochester MN, Minneapolis MN, Marshall MN, Madison WI,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Rochester MN, Columbus OH, Nashville TN, Denver CO,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase 1, Phase 2, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Rochester MN, Madison WI, West Des Moines IA,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Rare Kidney Stone Consortium Patient Registry

for
Primary Hyperoxaluria, Dent Disease, Cystinuria,
Location: Rochester MN, New York NY
Sponsor: Mayo Clinic

Sex: All

Age: 0 - 70+

Code: NCT00588562

Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

for
Amblyopia
Location: Rochester MN, La Crosse WI, Minneapolis MN, Sartell MN,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4 - 7

Code: NCT06380517

Phase 3, Recruiting

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Rochester MN, Minneapolis MN, Sartell MN, Iowa City IA,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase 3, Recruiting

Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

for
Demyelinating Diseases, Multiple Sclerosis,
Location: Rochester MN
Sponsor: Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul

Sex: All

Age: 18+

Code: NCT05605951

Recruiting

Determining How Indoor Lighting Affects the Brain Health of Older Adults

for
Sleep, Physical Activity, Cognitive Function, Social Isolation
Location: Rochester MN
Sponsor: Well Living Lab, Inc.

Sex: All

Age: 60+

Code: NCT05978934

Recruiting

Acute Stress Recovery

for
Stress
Location: Rochester MN
Sponsor: Well Living Lab, Inc.

Sex: All

Age: 18+

Code: NCT05298189

Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Rochester MN, Milwaukee WI, Omaha NE, Hinsdale IL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Rochester MN, Burnsville MN, Hudson WI, Woodbury MN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Rochester MN, Minneapolis MN, Dallas TX, Fairfax VA,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase 3, Recruiting